Effect of Long-Term Use of Bisphosphonates on Forearm Bone: Atypical Ulna Fractures in Elderly Woman with Osteoporosis.
Autor: | Erdem Y; Orthopedics and Traumatology Department, Girne Military Hospital, Kyrenia, Cyprus., Atbasi Z; Orthopedics and Traumatology Department, Ankara Military Hospital, Ankara, Turkey., Emre TY; Orthopedics and Traumatology Department, Memorial Hizmet Hospital, Istanbul, Turkey., Kavadar G; Physical Medicine and Rehabilitation Department, Medicine Hospital, Istanbul, Turkey., Demiralp B; Orthopedics and Traumatology Department, Medipol University Hospital, Istanbul, Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | Case reports in orthopedics [Case Rep Orthop] 2016; Vol. 2016, pp. 4185202. Date of Electronic Publication: 2016 Aug 10. |
DOI: | 10.1155/2016/4185202 |
Abstrakt: | Osteoporosis is a common musculoskeletal disease of the elderly population characterized by decreased bone mineral density and subsequent fractures. Bisphosphonates are a widely accepted drug therapy which act through inhibition of bone resorption and prevent fractures. However, in long-term use, atypical bisphosphonate induced fractures may occur, particularly involving the lower weight bearing extremity. Atypical ulna fracture associated with long-term bisphosphonate use is rarely reported in current literature. We present a 62-year-old woman with atypical ulna due to long-term alendronate therapy without a history of trauma or fall. Clinicians should be aware of stress fracture in a patient who has complaints of upper extremity pain and history of long-term bisphosphonate therapy. |
Databáze: | MEDLINE |
Externí odkaz: |